Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect

Lancet

Volumn 347, Issue 8997, 1996, Pages 295-297

  Chen, Hongwei ^a   Sandler, Dale P ^a,e   Taylor, Jack A ^a   Shore, David L ^b   Liu, Edison ^c,e   Bloomfield, Clara D ^d,e   Bell, Douglas A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Westat Inc   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e Cancer and Leukemia Group B (CALGB)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; BONE MARROW; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK;

EID: 0030034954     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90468-7     Document Type: Article

References (20)

1. Verwilghen RL, Boogaerts MA. The myelodsysplastic syndromes. Blood Rev 1987; 1: 34-43.
2. Cheson B. The myelodysplastic syndromes: current approaches to therapy. Ann Intern Med 1990; 112: 932-41.
3. Farrow A, Jacobs A, West RR. Myelodysplasia, chemical exposure and other environmental factors. Leukemia 1989; 3: 33-35.
4. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure. Semin Oncol 1992; 19: 47-84.
5. West RR, Stafford DA, Farrow A, Jacobs A. Occupational and environmental exposures and myelodysplasia: a case-control study. Leukemia Res 1995; 19: 127-39.
6. Idle J. Is environmental carcinogenesis modulated by host polymorphism? Mutat Res 1991; 247: 259-66.
7. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzymes of glutathione s-transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 1990; 11: 33-36.
8. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathiones-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 1159-64.
9. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 1988; 202: 343-61.
10. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85: 7293-97.
11. Pemble S, Schroeder K, Spencer S, et al. Human glutathione s-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemical J 1994; 300: 271-76.
12. Wiencke JK, Pemble S, Ketterer B, Keley KT. Gene deletion of glutathione transferase theta 1: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995; 4: 253-60.
13. Goasguen JE, Bennett JM. Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol 1992; 19: 4-13.
14. Kleinbaum DL, Kupper LL, Morgenstern H. Epidemiologic research principles and quantitative methods. New York: Reinhold, 1982.
15. Nelson H, Wiencke JK, Christiani D, et al. Ethnic differences in the prevalence of the homozygous deletion of glutathione s-transferase theta. Carcinogenesis 1995; 16: 1243-45.
16. Heagerty AHM, Fitzgerald D, Smith A, et al. Glutathione S-transferase GSTM1 phenotype and protection against cutaneous tumours. Lancet 1994; 343: 266-68.
17. Warwick A, Sarhanis P, Redman C, et al. Theta class glutahione s-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 1994; 15: 2841-45.
18. Chenevix-Trench G , Young J, Coggan M, Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 1995; 16: 1655-57.
19. Warholm M, Rane A, Alexandrie A, Monghan G, Rannug A. Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population. Pharmacogenetics 1995; 5: 252-54.
20. Tan KL, Webb GC, Baker RT, Board PG. Molecular cloning of a cDNA and chromosomal localization of a human theta-class glutathione S-transferase gene (GSTT2) to chromosome 22. Genomics 1995; 25: 381-87.